Dr. Jason Bock, CEO of CTMC, challenges the CDMO classification for his company. He shares CTMC's mission to aid early clinical-stage firms like KSQ Therapeutics enter their clinical stage successfully. The podcast explores the collaboration between CTMC and KSQ, discussing the challenges and innovations in cell therapy development, experienced groups in the Tills industry uniting, cultural alignment and technical collaborations in biotech partnerships, the power of aligned incentives in collaborations, and excitement in advancing clinical data sets and cell therapies.

The podcast features Ori Biotech CEO Jason Foster and the Cell Therapy Manufacturing Center's CEO, Jason Bock discussing the advancements in cell and gene therapy manufacturing. They explore the current state of manufacturing, potential of personalized medicines, hurdles in the industry, and innovative approaches being pioneered by new companies. Topics include automated manufacturing tech, challenges in quality control, revamping supply chains, and accelerating the transformation of therapies.